Berberine-loaded polylactic acid nanofiber scaffold as a drug delivery system: The relationship between chemical characteristics, drug-release behavior, and antibacterial efficiency

• Le Thi Le,
• Hue Thi Nguyen,
• Liem Thanh Nguyen,
• Huy Quang Tran and
• Thuy Thi Thu Nguyen

Beilstein J. Nanotechnol. 2024, 15, 71–82, doi:10.3762/bjnano.15.7

• been employed to produce nanoformulations of drugs for endowing a better therapeutic effect. The nanoformulations for drug delivery can be designed using nanocarrier systems, including organic materials (liposomes, nanoemulsions, nanomicelles, and nanofibers) and inorganic nanoparticles (gold, silver

Curcumin-loaded nanostructured systems for treatment of leishmaniasis: a review

• Douglas Dourado,
• Thayse Silva Medeiros,
• Éverton do Nascimento Alencar,
• Edijane Matos Sales and
• Fábio Rocha Formiga

Beilstein J. Nanotechnol. 2024, 15, 37–50, doi:10.3762/bjnano.15.4

• higher. In vivo studies demonstrated that the nanoformulations were more effective in reducing parasitemia in the spleen, with results equivalent to the group treated with amphotericin B. Das and collaborators, on the other hand, addressed the development of nanostructured lipid carriers (NLC) with

• administration in cutaneous and mucocutaneous leishmaniasis [81]. The systems were produced by homogenization using a vortex mixer. The authors obtained two nanoformulations, which showed droplet size between 26–29 nm, polydispersity index (PdI) lower than 0.2, and zeta potential between −3.6 and −4.4 mV. The

• curc-SNEDDSs (1% of curc) promoted an increase in antileishmanial (in vitro) activity (IC50: 0.13–0.18 µg/mL and 0.25–0.27 µg/mL) when compared to curc in its free form (IC50: 22.50–24.60 µg/mL) against promastigote and amastigote forms of Leishmania tropica, respectively. The nanoformulations were

Nanotechnological approaches in the treatment of schistosomiasis: an overview

• Lucas Carvalho,
• Michelle Sarcinelli and
• Beatriz Patrício

Beilstein J. Nanotechnol. 2024, 15, 13–25, doi:10.3762/bjnano.15.2

• identified works presented results in the clinical phase. Finally, based on our findings, the outlook appears favorable, as there is a significant diversity of new substances with schistosomicidal potential. However, financial efforts are required to advance these nanoformulations. Keywords: delivery system

• also brings disadvantages, such as occurrence of resistant strains, low bioavailability [47], and organoleptic characteristics such as bitter taste [29][48]. In the literature, it is described that nanoformulations approaches can overcome these drawbacks. Most publications used nanotechnology to alter

• pharmacokinetics parameters. The nanoformulations were evaluated through efficacy criteria (e.g., parasite burden, egg counts, and granuloma diameter) or using traditional pharmacokinetics parameters (e.g., absorption rate or bioavailability). For example, Labib El Gendy et al. [49] showed that PZQ encapsulated in

Sulfur nanocomposites with insecticidal effect for the control of Bactericera cockerelli

• Lany S. Araujo-Yépez,
• Juan O. Tigrero-Salas,
• Vicente A. Delgado-Rodríguez,
• Vladimir A. Aguirre-Yela and
• Josué N. Villota-Méndez

Beilstein J. Nanotechnol. 2023, 14, 1106–1115, doi:10.3762/bjnano.14.91

• ]. Furthermore, different kinds of polysaccharides (e.g., chitosan, alginates, and polyethylene glycol) have been used for the synthesis of nanoinsecticides [15]. While other forms of polymer and non-polymer nanoformulations, such as nanofibers, nanocapsules, nanogels, nanomicelles, and nanospheres, have been

• potential botanical sources for developing new insecticides [25]. Their active components act against pest species through toxicant and repellent effects, developmental and behavioral alterations, and induction of sterility or infertility of insects [26]. Technologies such as nanoformulations or

• lipophilic and, thus, can enter the insect and cause biochemical dysfunction and mortality [50]. Rosemary essential oil-laden nanoformulations have shown significant insecticidal activity for the effective management of the red beetle Tribolium castaneum [51]. Another study claimed that eucalyptus essential

Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies

• Giuliana Muraca,
• María Esperanza Ruiz,
• Rocío C. Gambaro,
• Sebastián Scioli-Montoto,
• María Laura Sbaraglini,
• Gisel Padula,
• José Sebastián Cisneros,
• Cecilia Yamil Chain,
• Vera A. Álvarez,
• Cristián Huck-Iriart,
• Guillermo R. Castro,
• María Belén Piñero,
• Matias Ildebrando Marchetto,
• Catalina Alba Soto,
• Germán A. Islan and
• Alan Talevi

Beilstein J. Nanotechnol. 2023, 14, 804–818, doi:10.3762/bjnano.14.66

• required to test this hypothesis. Conclusion Among the spectra of nanoformulations encapsulating BNZ that exist to date, the nanoparticles presented in this work might be considered a novelty in terms of the lipid and manufacturing technique of choice. We achieve physical stability for at least six months

Recent progress in cancer cell membrane-based nanoparticles for biomedical applications

• Qixiong Lin,
• Yueyou Peng,
• Yanyan Wen,
• Xiaoqiong Li,
• Donglian Du,
• Weibin Dai,
• Wei Tian and
• Yanfeng Meng

Beilstein J. Nanotechnol. 2023, 14, 262–279, doi:10.3762/bjnano.14.24

• various medical fields, such as cardiovascular diseases, neurological diseases, malignant neoplasm, orthopedic diseases, and immune system diseases, providing a new approach to various treatment problems [3]. These nanoformulations provide advantages over conventional pharmaceutical formulations in terms

• of safety and efficiency. However, there are still many inadequacies that limit the application of nanoformulations in biomedicine, including limited tumor penetration and insufficient specificity. Furthermore, nanoformulations are often recognized as foreign materials by the reticuloendothelial

• interact with other cells. The biological effects of nanoformulations can be enhanced through the effective utilization of specific protein groups. A schematic diagram of surface proteins and functions of the cancer cell membrane is shown in Figure 2. 2.1 Homologous targeting Cancer cells usually exhibit

Orally administered docetaxel-loaded chitosan-decorated cationic PLGA nanoparticles for intestinal tumors: formulation, comprehensive in vitro characterization, and release kinetics

• Sedat Ünal,
• Osman Doğan and
• Yeşim Aktaş

Beilstein J. Nanotechnol. 2022, 13, 1393–1407, doi:10.3762/bjnano.13.115

• obstacles for successful treatment [15]. The low permeability of nanoformulations through the mucus layer prevents sufficient absorption of the drug and causes clearance of molecules which do not reach adequate retention time in the GIT [53]. Thus, increasing the retention time of the NPs on the mucus layer

Antibacterial activity of a berberine nanoformulation

• Hue Thi Nguyen,
• Tuyet Nhung Pham,
• Anh-Tuan Le,
• Nguyen Thanh Thuy,
• Tran Quang Huy and
• Thuy Thi Thu Nguyen

Beilstein J. Nanotechnol. 2022, 13, 641–652, doi:10.3762/bjnano.13.56

• types of nanoformulations, such as polymer-, lipid-, dendrimer-, graphene-, gold-, or silver-based nanoparticles, have been used for the delivery of BBR [29][30][31]. Yu et al. [29] prepared poly(ethylene glycol)–lipid–poly(lactic-co-glycolic acid) nanoparticles loaded with BBR to improve the oral

• delivery efficiency of BBR. This nanoformulation increased the oral relative bioavailability to approximately 343% compared to that of the original BBR. Although nanoformulations have emerged as an effective approach to improve the bioavailability of BBR, several drawbacks should be addressed as follows

• : (1) Almost all drug-carrying nanomaterials have high cost, (2) the drug concentration of the encapsulated form is usually low, and (3) the toxicity risk of nanomaterials must be strictly controlled [32][33][34]. Most nanoformulations have relatively low drug loading (typically a few weight percent

Ethosomal (−)-epigallocatechin-3-gallate as a novel approach to enhance antioxidant, anti-collagenase and anti-elastase effects

• Çiğdem Yücel,
• Gökçe Şeker Karatoprak,
• Sena Yalçıntaş and
• Tuğba Eren Böncü

Beilstein J. Nanotechnol. 2022, 13, 491–502, doi:10.3762/bjnano.13.41

• the solution form of EGCG was found to be significantly lower with nanoformulations. It is thought that this low inhibition failed to maintain the efficacy of the solution form throughout the experiment, whereas sustained release formulations provided higher inhibition. Previous studies have proven

Use of nanosystems to improve the anticancer effects of curcumin

• Andrea M. Araya-Sibaja,
• Norma J. Salazar-López,
• Krissia Wilhelm Romero,
• José R. Vega-Baudrit,
• J. Abraham Domínguez-Avila,
• Carlos A. Velázquez Contreras,
• Ramón E. Robles-Zepeda,
• Mirtha Navarro-Hoyos and
• Gustavo A. González-Aguilar

Beilstein J. Nanotechnol. 2021, 12, 1047–1062, doi:10.3762/bjnano.12.78

• materials for nanomedical applications. Imaging-guided drug delivery of CUR-based nanosystems may also directly target specific cells, thereby increasing the therapeutic and chemopreventive efficacy of this versatile compound. Keywords: nanocarrier; nanoformulations; nanosized delivery systems; phenolic

• internalization, as compared to conventional therapies, potentially increasing therapeutic efficacy and minimizing side effects [4]. Nanosystems can be referred to as nanocarriers, nanoformulations, nanosized-delivery systems, and other similar terms. They have been utilized in the design of cellular and

Identification of physicochemical properties that modulate nanoparticle aggregation in blood

• Ludovica Soddu,
• Duong N. Trinh,
• Eimear Dunne,
• Dermot Kenny,
• Giorgia Bernardini,
• Ida Kokalari,
• Arianna Marucco,
• Marco P. Monopoli and
• Ivana Fenoglio

Beilstein J. Nanotechnol. 2020, 11, 550–567, doi:10.3762/bjnano.11.44

• the bloodstream is particularly relevant not only for nanoformulations administered by intravenous injection, but also for any material that is introduced into the body by other routes as they have the potential to cross biological barriers and subsequently enter into the bloodstream. Previous studies

Targeted therapeutic effect against the breast cancer cell line MCF-7 with a CuFe₂O₄/silica/cisplatin nanocomposite formulation

• B. Rabindran Jermy,
• Vijaya Ravinayagam,
• Widyan A. Alamoudi,
• Dana Almohazey,
• Hatim Dafalla,
• Lina Hussain Allehaibi,
• Abdulhadi Baykal,
• Muhammet S. Toprak and
• Thirunavukkarasu Somanathan

Beilstein J. Nanotechnol. 2019, 10, 2217–2228, doi:10.3762/bjnano.10.214

• . Copper ferrite and cisplatin functional groups were identified using FTIR using ATR technology (Perkin Elmer, USA). The morphological features of the nanoformulations were identified by SEM and TEM. The elemental distribution in the samples was investigated using SEM-EDS. SEM was performed using a JSM

• /HYPS, CuFe2O4/AlMSU-F and CuFe2O4/silicalite nanoformulations. The cellulose membrane dialysis tubing was activated, and drug delivery was performed by immersing the bag containing 30 mg of drug formulations in 50 mL of phosphate buffered saline (PBS) at pH 5.6. The release was performed under constant

• particular, CuFe2O4/HYPS showed a high adsorption of about 88.6%. On the other hand, CuFe2O4/Al-MSU-F and CuFe2O4/silicalite showed an adsorption of up to 87.2% and 85.3%, respectively. Among the different nanoformulations, the order of cisplatin drug release was as follows: CuFe2O4/HYPS > CuFe2O4/Al-MSU-F

Targeting strategies for improving the efficacy of nanomedicine in oncology

• Gonzalo Villaverde and
• Alejandro Baeza

Beilstein J. Nanotechnol. 2019, 10, 168–181, doi:10.3762/bjnano.10.16

• solutions, a real alternative? Active targeting is already one of the most used strategies for bringing nanoformulations into tumoral cells. Although usually great results were achieved in vitro, the in vivo assays have shown smaller effects regarding cell internalization. There has been no real enhancement

Enhanced antineoplastic/therapeutic efficacy using 5-fluorouracil-loaded calcium phosphate nanoparticles

• Shanid Mohiyuddin,
• Saba Naqvi and
• Gopinath Packirisamy

Beilstein J. Nanotechnol. 2018, 9, 2499–2515, doi:10.3762/bjnano.9.233

• immediately on improving the efficacy. This need could possibly be met by a nanoscale-carrier-facilitated drug delivery system. This rapidly growing field of research has gained interest all over the world with its effective and targeted drug delivery application [3]. Polymer-based nanoformulations have

• nanomaterial was found to be toxic in some metal-based NPs (e.g., gold, silver, iron, and copper), while the bulk counterparts showed less toxicity [9]. The metal ions present at the surface of the particles were found to interact with biomolecules at a comparatively higher rate in nanoformulations compared to

Near-infrared dye loaded polymeric nanoparticles for cancer imaging and therapy and cellular response after laser-induced heating

• Tingjun Lei,
• Alicia Fernandez-Fernandez,
• Romila Manchanda,
• Yen-Chih Huang and
• Anthony J. McGoron

Beilstein J. Nanotechnol. 2014, 5, 313–322, doi:10.3762/bjnano.5.35

• NPs do not have any cytotoxicity effect at this concentration. Optical imaging of cancer cells and mice showed that the use of the NP formulation resulted in a stronger fluorescence signal 24 h after injection. This is consistent with the literature reporting that nanoformulations can result in